Porvair Expands Its Operations at New Milton
News Feb 13, 2014
Porvair Filtration Group has announced the expansion of its UK facilities in New Milton near Christchurch. The new factory purchased this month will allow a consolidation of Porvair’s business in the UK and provides much needed manufacturing capacity to support the future growth of the business.
Porvair Filtration Group, whose parent company, Porvair plc, saw revenues grow by 10% last year, will consolidate its activities in the market for industrial filtration and separation products on the new site. Tom Liddell, Managing Director of Porvair Filtration Group commented, ‘At over 40,000 square feet, the new facility will allow us to integrate a number of activities within smaller units in the area, gaining efficiency in our operations and giving us space to sustain our growth. The investment is significant, but it is consistent with the sizeable growth opportunity we see for our products in the industrial process market.’
Porvair Filtration Group has supplied the process industry for over 25 years, with innovative and performance driven filtration equipment (elements, cartridges and vessels). The process industry demands filters that can withstand the most extreme and aggressive conditions of temperature, pressure and corrosion, whilst safeguarding operators and systems from particulates and ensuring environmental protection. Each filtration and separation requirement presents its own critical challenges and requires superior reliability, durability and a robust product construction. Porvair Filtration Group provide highly specialised filtration solutions for use throughout the manufacturing process and have proven filtration solutions for the production of chemicals such as nitric acid, maleic anhydride, caprolactum, hydrogen peroxide, sulphuric acid, phosphoric acid, magnesium nitrate, as well as HDPE and LLDPE. By using the latest in metallic filter media technology, Porvair are able to provide improved performance, and reduced plant operating costs, enabling longer campaigns and greater materials recovery.
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Compound as Effective as FDA-Approved Drugs Against Life-Threatening InfectionsNews
Purdue University researchers have identified a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the Food and Drug Administration to treat life-threatening infections while also appearing to be less susceptible to bacterial resistance.READ MORE